Knapp Katherine K, Cultice James M
College of Pharmacy, Touro University, Vallejo, CA 94592, USA.
J Am Pharm Assoc (2003). 2007 Jul-Aug;47(4):463-70. doi: 10.1331/JAPhA.2007.07003.
To revise the 2000 Bureau of Health Professions Pharmacist Supply Model based on new data.
Stock-flow model.
United States.
A 2004 estimate of active pharmacists reported by the Bureau of Labor Statistics was used to derive the base count for the 2007 supply model.
Starting with a 2004 base of active pharmacists, new graduates are added to the supply annually and losses resulting from death and retirement are subtracted.
Age- and gender-based pharmacist supply estimates, 2004-2020.
Increased U.S. pharmacist supply estimates (236,227 in 2007 to 304,986 in 2020) indicate that pharmacists will remain the third largest professional health group behind nurses and physicians. Increases were driven by longer persistence in the workforce (59%), increased numbers of U.S. graduates (35%), and increases from international pharmacy graduates (IPGs) achieving U.S. licensure (6%). Since more pharmacists are expected to be working part time the full-time equivalent (FTE) supply will be reduced by about 15%. The mean age of pharmacists was projected to decline from 47 to 43 by 2020. Because of unequal distribution across age groups, large pharmacist cohorts approaching retirement age will result in fewer pharmacists available to replace them. The ratio of pharmacists to the over-65 population is expected to decrease after 2011 and continue to fall beyond 2020; this is likely a reflection of baby boomers passing through older age cohorts.
The revised estimated active U.S. pharmacist head count in 2006 is 232,597, with equivalent FTEs totaling approximately 198,000. The substantial increase over the 2000 pharmacist supply model estimates is primarily attributable to pharmacists remaining in the workforce longer and educational expansion. U.S. licensed IPGs account for less than 6% of overall increases. The pharmacist work-force is projected to become younger on average by about 4 years by 2020. Coincident demands for more physicians and nurses over the same period and shortages in all three professions stipulate that active steps be taken, including continued monitoring of work trends among pharmacists and other health professionals.
基于新数据修订2000年卫生专业人员局药剂师供应模型。
存量-流量模型。
美国。
劳工统计局2004年对在职药剂师的估计数用于得出2007年供应模型的基数。
从2004年在职药剂师基数开始,每年新增毕业生加入供应队伍,并减去因死亡和退休导致的流失人数。
2004年至2020年按年龄和性别划分的药剂师供应估计数。
美国药剂师供应估计数增加(从2007年的236,227人增至2020年的304,986人),这表明药剂师仍将是仅次于护士和医生的第三大专业卫生群体。增长的驱动因素包括劳动力留存时间延长(59%)、美国毕业生人数增加(35%)以及获得美国执照的国际药学毕业生人数增加(6%)。由于预计更多药剂师将从事兼职工作,全职等效(FTE)供应量将减少约15%。预计到2020年药剂师的平均年龄将从47岁降至43岁。由于各年龄组分布不均,接近退休年龄的药剂师群体庞大,可供替代他们的药剂师数量将减少。预计2011年后药剂师与65岁以上人口的比例将下降,并在2020年后继续下降;这可能反映了婴儿潮一代步入老年群体的情况。
2006年美国在职药剂师估计人数修订后为232,597人,全职等效人数总计约198,000人。相对于2000年药剂师供应模型估计数的大幅增加,主要归因于药剂师在劳动力队伍中留存时间延长以及教育扩张。获得美国执照的国际药学毕业生占总增长人数的比例不到6%。预计到2020年药剂师劳动力队伍平均年龄将年轻约4岁。同期对更多医生和护士的需求以及这三个专业的短缺情况表明,需要采取积极措施,包括持续监测药剂师和其他卫生专业人员的工作趋势。